intrathecal 15 mg 0.5% ropivacaine with 25 mcg fentanyl (Group RF)	15 mg 0.5% bupivacaine with 25 mcg fentanyl (Group BF)	Time required to reach highest sensory level, complete motor block	1030	1107	Time to reach highest sensory level and complete motor block were comparable.
intrathecal 15 mg 0.5% ropivacaine with 25 mcg fentanyl (Group RF)	15 mg 0.5% bupivacaine with 25 mcg fentanyl (Group BF)	Time required to reach highest sensory level, complete motor block	8846	9180	Time required to reach highest sensory level (Group RF - 6.86 ± 3.73 min, Group BF - 7.07 ± 2.99 min, P = 0.34), complete motor block (Group RF - 6.02 ± 2.1 min, Group BF - 6 ± 3.6 min, P = 0.31) and sensory regression to L1 dermatome (Group RF - 226 ± 46.98 min and Group BF - 229.33 ± 50.51 min, P = 0.36) were comparable [Table 2].
intrathecal 15 mg 0.5% ropivacaine with 25 mcg fentanyl (Group RF)	15 mg 0.5% bupivacaine with 25 mcg fentanyl (Group BF)	The motor recovery to Bromage scale 1	1221	1343	The motor recovery to Bromage scale 1 was faster in Group RF (242.8 ± 47.06 min) than Group BF (268 ± 49.9 min) P = 0.023.
intrathecal 15 mg 0.5% ropivacaine with 25 mcg fentanyl (Group RF)	15 mg 0.5% bupivacaine with 25 mcg fentanyl (Group BF)	Time for rescue analgesia	1344	1472	Time for rescue analgesia was prolonged in Group BF (263.33 ± 63 min) when compared to Group RF (234.44 ± 58.76 min), P = 0.021.
intrathecal 15 mg 0.5% ropivacaine with 25 mcg fentanyl (Group RF)	15 mg 0.5% bupivacaine with 25 mcg fentanyl (Group BF)	Sensory regression to L1 dermatome	9046	9180	sensory regression to L1 dermatome (Group RF - 226 ± 46.98 min and Group BF - 229.33 ± 50.51 min, P = 0.36) were comparable [Table 2].
intrathecal 15 mg 0.5% ropivacaine with 25 mcg fentanyl (Group RF)	15 mg 0.5% bupivacaine with 25 mcg fentanyl (Group BF)	Sensory regression to L1 dermatome	1108	1219	Sensory regression to L1 dermatome was 226 ± 46.98 min in Group RF and 229.33 ± 50.51 min in Group BF, P = 0.36
